The goal of this 5-year proposal is to continue the federally supported activities of a unique Mental Health Clinical Research Center for the multi-disciplinary study of anxiety disorders, anxiety symptoms and related disorders. Interlocking core facilities provide the resources for substantive research conducted both by the MHCRC participants and a wide range of other investigators within the Department of Psychiatry and the New York State Psychiatric Institute and collaborating institutions. The new MHCRC proposal maintains our current core facilities. These include the Research Assessment and Training Unit (Jean Endicott, Ph.D.), the Biological Studies Unit (Jack Gorman, N.D.), the Biostatistics and Data Management Unit (Donald Ross, Ph.D.) the Analytical Psychopharmacology Unit (Thomas Cooper, MA), the Molecular Genetics Unit (Conrad Gilliam, Ph.D.), the Diagnostic and Recruitment Centers for normal volunteers (Jean Endicott, Ph.D) and anxiety patients (Michael Liebowitz, M.D.), as well as our Open Treatment Center (Michael Liebowitz, M.D.). The MHCRC at New York State Psychiatric Institute continues to be a model for the field of psychiatric research. It integrates major support from the city, state, university, a voluntary hospital, foundations, and federal project grants around a stable set of federally funded Core Facilities. The entire mechanism is devoted to research and training in the context of excellent patient care.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH030906-18
Application #
2244263
Study Section
Special Emphasis Panel (SRCM (07))
Project Start
1978-08-01
Project End
1999-07-31
Budget Start
1995-08-01
Budget End
1996-07-31
Support Year
18
Fiscal Year
1995
Total Cost
Indirect Cost
Name
New York State Psychiatric Institute
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Hodges, Laura M; Fyer, Abby J; Weissman, Myrna M et al. (2014) Evidence for linkage and association of GABRB3 and GABRA5 to panic disorder. Neuropsychopharmacology 39:2423-31
Fyer, Abby J; Costa, Ramiro; Haghighi, Fatemeh et al. (2012) Linkage analysis of alternative anxiety phenotypes in multiply affected panic disorder families. Psychiatr Genet 22:123-9
Preter, M; Lee, S H; Petkova, E et al. (2011) Controlled cross-over study in normal subjects of naloxone-preceding-lactate infusions; respiratory and subjective responses: relationship to endogenous opioid system, suffocation false alarm theory and childhood parental loss. Psychol Med 41:385-93
Brisbin, Abra; Weissman, Myrna M; Fyer, Abby J et al. (2010) Bayesian linkage analysis of categorical traits for arbitrary pedigree designs. PLoS One 5:e12307
Schechter, Dianne; Endicott, Jean; Nee, John (2007) Quality of life of 'normal'controls: association with lifetime history of mental illness. Psychiatry Res 152:45-54
Simpson, H B; Tenke, C E; Towey, J B et al. (2000) Symptom provocation alters behavioral ratings and brain electrical activity in obsessive-compulsive disorder: a preliminary study. Psychiatry Res 95:149-55
Simpson, H B; Gorfinkle, K S; Liebowitz, M R (1999) Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial. J Clin Psychiatry 60:584-90
Simpson, H B; Schneier, F R; Campeas, R B et al. (1998) Imipramine in the treatment of social phobia. J Clin Psychopharmacol 18:132-5